Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Rising rates of interval breast cancers have experts calling for more risk-based screenings
A new analysis suggests interval cancer rates among women with a prior history of breast cancer may be as high as 30%.
Rates of breast cancer diagnosis, death expected to climb in coming decades
By 2050, new cases could rise by up to 38%, while deaths may see a steeper climb, potentially increasing 68%, according to new research from WHO.
AI quantifies breast arterial calcifications on mammograms
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Opportunistic screening: AI highlights key heart findings in mammography images
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.

Abbreviated MRI protocols present suitable alternatives for liver cancer screening

Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.

Routine abdominal CTs offer insight into cardiovascular risk

During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

Screening efforts have helped avert millions of cancer-related deaths in recent decades

In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

What breast density status can tell us about cardiovascular risk

Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Patients without PCPs struggle to access lung cancer screening, despite eligibility

It is estimated that up to one-third of the U.S. population does not have a primary care provider.

Breast cancer rates among women in their 30s are on the rise

Screening uptake for younger women has been steadily rising for years. Consequently, so have cancer rates among the population.

Radiologist Dana Ataya, MD, writes song to clear up confusion on breast cancer screening recs.

Singing radiologist pens song to clear up confusion about breast cancer screening recs

Dana Ataya, MD, is backed by Moffitt Cancer Center's band, The ReMissions.

Screening

Rising rates of interval breast cancers have experts calling for more risk-based screenings

Rates of breast cancer diagnosis, death expected to climb in coming decades

AI quantifies breast arterial calcifications on mammograms

Opportunistic screening: AI highlights key heart findings in mammography images

AI 'not safe' to be implemented as a solo reader for breast cancer screening exams